Literature DB >> 34130957

Areca nut consumption with and without tobacco among the adult population: a nationally representative study from India.

Prashant Kumar Singh1,2, Amit Yadav3, Lucky Singh4, Sumit Mazumdar5, Dhirendra N Sinha6, Kurt Straif7,8, Shalini Singh2,9.   

Abstract

OBJECTIVE: Areca nut is one of the most widely consumed substances globally, after nicotine, ethanol and caffeine and classified as carcinogenic to humans. This study examines the disparity and determinants of areca nut consumption with and without tobacco in India.
DESIGN: Nationally representative cross-sectional study. PARTICIPANTS: We used the nationally representative Global Adult Tobacco Survey 2016-2017. The analytical sample size was 74 037 individual's aged 15 years and above with a response rate of 92.9%. MEASURES: Current consumption of areca nut without tobacco and with tobacco.
METHOD: We examined determinants of areca nut consumption (without tobacco and with tobacco) using multinomial logistic regression, accounting for the survey design.
RESULTS: About 23.9% (95% CI 23.1 to 24.8) of the adult population consume areca nut, that is, approximately 223.79 million people in India; majority of users (14.2%-95% CI 13.5 to 14.9) consumed areca nut with tobacco. When compared with women, men were more likely to consume areca nut (with tobacco relative risk (RR)=2.02; 95% CI 1.85 to 2.21 and without tobacco RR=1.13; 95% CI 1.07 to 1.20). Age, marital status, education, occupation, caste, religion and region were significantly associated with areca nut consumption. However, the direction and magnitude of association differ with respect to the areca nut consumption with and without tobacco.
CONCLUSION: The ongoing tobacco control efforts would not address the majority of areca nut users until greater attention to areca nut consumption with and without tobacco is reflected in health policies in India. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer pain; health policy; public health

Year:  2021        PMID: 34130957     DOI: 10.1136/bmjopen-2020-043987

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  3 in total

Review 1.  Risk of liver disease in areca nut habitual: A systematic review.

Authors:  Suwarna B Dangore Khasbage; Rahul R Bhowate; Nazli Khatib
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

2.  How Do Adolescents Assess and Rank the Risk of Areca Nut Use? Findings from a Study in Mumbai, India.

Authors:  Nilesh Chatterjee; Himanshu A Gupte; Gauri Mandal
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

3.  Using the Theory of Planned Behavior to Explain and Predict Areca Nut Use Among Adolescents in India: An Exploratory Study.

Authors:  Himanshu A Gupte; Nilesh Chatterjee; Gauri Mandal
Journal:  Subst Abuse Rehabil       Date:  2022-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.